Inside This Issue: Post-Traumatic Stress Disorder
Top News Alerts: Product Updates, Deals & Financings
Event Highlights: CNS Leaders Forum, BioMEDevice Forum
Company Spotlight: PAX Neuroscience
Subscribe now to access over 30 articles covering developments in drugs, devices and diagnostics for the brain and nervous system.
Market Highlights: Major Players Finally Get Serious About Biomarkers
Big Pharma has always touted the need for biomarkers and adesire to move towards personalized medicine but, until very recently, this has been little more than lip service. In the CNS field, everyone agrees that current FDA endpoints relying only on symptomatic readouts are too time consuming, expensive, and variable, but few have stepped up to invest in biomarker technology. Biomarker and diagnostic companies were left struggling to find funding and collaborators to execute the necessary studies to definitively prove the usefulness of their platforms clinically. All that now appears to be changing…
PTSD: Rising Awareness, Few Options
The awareness and understanding of PTSD is on the rise as troops return from Iraq and Afganistan. Combined with civilian cases the number of impacted Americans is nearly 8 million. Serious therapeutic development is still lagging, but several companies and researchers are leveraging government funding to explore the possibilities...
PAX Neuroscience: Molecular Diagnostics to Inform Treatment Decisions
PAX Neuroscience is a molecular diagnostics startup founded in January 2009. The company is working to commercialize discoveries made by its scientific founder, Dr. Mark Rasenick, a professor at the University of Illinois in Chicago. The company is largely virtual and is run by Dr. Debra Bass, president and CEO, who is a long-time friend of Dr. Rasenick. PAX is developing a blood test that detects translocation of a biomarker into different membrane domains in response to antidepressants...
Companies Covered In This Issue Include: Rules-based Medicine, NeuroMEDx, Functional Neuromodulation, Ceregene, AcelRx, Orasi Medical, Vycor, Trigemina, Evotec, Merck, Zogenix, Evotec, Merck, Medtronic, Ardian, Somaxon, Xention, Yaupon, EndoStim, Transgenomic, Allon, Xenoport, MJ Fox Foundation, Eli Lilly, Pfizer, NeuroVigil, Trifectas Medical, NeoStim, Johnson and Johnson, Elan, BrainCells, Azevan, Tonix, Cynapsys, GW Pharma, Pacira, Alnylam, Medtronic, Arcion, CHDI Foundation, Surmodics, Edge Therapeutics, Avid Radiopharmaceuticals, 23andMe, Acadia, Neuropace, Impax, Neuraltus, CNS Therapeutics, Cyrenaic, Endo Pharmaceuticals, Oxford Biomedica, Boston Scientific, Arena Pharmaceuticals, 7TM Pharma, StemCells, Suven, Catalyst Pharma, Xanodyne, Regeneron, Advanced Cell Technology, Neuralstem, Vivus, Neuraxon, Ernest Gallo Clinic and Research Center, CeNeRx, Newron, EnVivo, Enteromedics, Cadence
Special Holiday Offer! Sign up for a new subscription in December and get a new iPod Nano for the Holidays! Simply complete the order below and we will follow by email to confirm color and shipping details.
Subscribe Now:
|
|
